Himchan Hospital and Busan Catholic University developed a rapid detection diagnostic kit for artificial joint infection and antibiotic resistance bacteria
Oct 28, 2025
Through a joint R&D project with a research team led by Professor Kim Sung-hyun of the Department of Clinical Pathology at Busan Catholic University, Lee Soo-chan's research team developed a molecular diagnostic kit for in vitro diagnostic medical devices that can quickly and accurately detect infections with prosthetic joint (PJI) and antibiotic-resistant bacteria.
The newly developed molecular diagnosis kit for detecting causative bacteria of PJI can quickly and accurately detect the causative bacterial genes of Prosthetic Joint Infection (PJI) through real-time polymerase chain reaction (Real-time PCR).
In addition, the rapid simultaneous detection of antibiotic-resistant bacteria molecular diagnostic kit' detects methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (Vancomycin-resistant enterococci) simultaneously and rapidly, which are major causes of resistant bacterial infection. Even in case of overlapping infection, each target gene can be accurately identified with high sensitivity.
This technology development is a research result that combines clinical specimen-based research support using the expertise of the infection diagnosis field by the research team of CEO Lee Soo-chan of Himchan Hospital and the ability of the research team at Busan Catholic University to develop molecular diagnosis technology. The two research teams plan to contribute to strengthening domestic technological independence and improving diagnostic accuracy in the field of infection diagnosis through continuous joint research in the future.
Meanwhile, papers related to this study were published in domestic journals 'Biomedical Science Letters' and overseas journals 'Microorganisms' and 'Pathogens', respectively.
The newly developed molecular diagnosis kit for detecting causative bacteria of PJI can quickly and accurately detect the causative bacterial genes of Prosthetic Joint Infection (PJI) through real-time polymerase chain reaction (Real-time PCR).
In addition, the rapid simultaneous detection of antibiotic-resistant bacteria molecular diagnostic kit' detects methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (Vancomycin-resistant enterococci) simultaneously and rapidly, which are major causes of resistant bacterial infection. Even in case of overlapping infection, each target gene can be accurately identified with high sensitivity.
This technology development is a research result that combines clinical specimen-based research support using the expertise of the infection diagnosis field by the research team of CEO Lee Soo-chan of Himchan Hospital and the ability of the research team at Busan Catholic University to develop molecular diagnosis technology. The two research teams plan to contribute to strengthening domestic technological independence and improving diagnostic accuracy in the field of infection diagnosis through continuous joint research in the future.
Meanwhile, papers related to this study were published in domestic journals 'Biomedical Science Letters' and overseas journals 'Microorganisms' and 'Pathogens', respectively.
|
This article was translated by Naver AI translator.
